By knockdown FASN in CAFs or inhibiting CRC cells uptake of fatty acids by SSO in vitro or CD36 monoclonal antibody in vivo, migration promotion effect of CAFs on CRC cells is partially reversed. This evidence concerns the gene CD36 and colorectal carcinoma.